GlassScriptPhysician profile
Folasade Oladapo
NPI 1346532934
$5,266.46
in general payments reported to CMS, 2019-2025
9 companies · $3,051 in 2025
The $3,051 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $640 · 2021: $1,251 · 2022: $58.21 · 2023: $111 · 2024: $18.93 · 2025: $3,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,729 · Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,728.78 |
| Food and Beverage | $1,452.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,016.37 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Vertos Medical, INC. | $624.22 | 2020 | |
| Spr Therapeutics, INC | $384.86 | 2022-2025 | Sprint Pns System |
| Si-Bone, INC. | $87.69 | 2025 | |
| Stryker Corporation | $47.28 | 2019-2024 | Spinejack |
| Abbott Laboratories | $37.35 | 2020-2022 | |
| Orthofix Medical, INC. | $33.66 | 2025 | Spinal-Stim |
| Medtronic, INC. | $18.50 | 2023 | Intellis Adaptivestim |
| Avanos Medical | $16.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Folasade Oladapo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.